|
GB9919413D0
(en)
|
1999-08-18 |
1999-10-20 |
Zeneca Ltd |
Chemical compounds
|
|
AU7962200A
(en)
*
|
1999-10-29 |
2001-05-14 |
Wakunaga Pharmaceutical Co., Ltd |
Novel indole derivatives and drugs containing the same as the active ingredient
|
|
CZ20032829A3
(cs)
*
|
2001-04-16 |
2005-03-16 |
Tanabe Seiyaku Co., Ltd. |
Heterocyklické sloučeniny
|
|
WO2003016291A1
(en)
|
2001-08-10 |
2003-02-27 |
Nippon Chemiphar Co., Ltd. |
ACTIVATOR FOR PEROXISOME PROLIFERATOR-RESPONSIVE RECEPTOR δ
|
|
MXPA04003398A
(es)
|
2001-10-12 |
2004-11-22 |
Nippon Chemiphar Co |
Activador para el receptor o activado con el proliferador de peroxisoma.
|
|
EA200700243A1
(ru)
*
|
2004-07-14 |
2007-08-31 |
ПиТиСи ТЕРАПЬЮТИКС, ИНК. |
Способы лечения гепатита с
|
|
MX2007004525A
(es)
*
|
2004-10-12 |
2007-09-19 |
Decode Genetics Inc |
Sulfonamidas biciclicas peri-sustituidas para enfermedad de arteria oclusiva.
|
|
WO2006046683A1
(en)
*
|
2004-10-25 |
2006-05-04 |
Astellas Pharma Inc. |
Thiazolylbenzofuran derivatives as leukotriene and prostaglandin d2 receptor antagonists
|
|
US8399666B2
(en)
|
2005-11-04 |
2013-03-19 |
Panmira Pharmaceuticals, Llc |
5-lipoxygenase-activating protein (FLAP) inhibitors
|
|
GB2431927B
(en)
*
|
2005-11-04 |
2010-03-17 |
Amira Pharmaceuticals Inc |
5-Lipoxygenase-activating protein (FLAP) inhibitors
|
|
US7977359B2
(en)
|
2005-11-04 |
2011-07-12 |
Amira Pharmaceuticals, Inc. |
5-lipdxygenase-activating protein (FLAP) inhibitors
|
|
AU2007214434B2
(en)
*
|
2006-02-15 |
2012-06-14 |
Allergan, Inc. |
Indole-3-carboxylic acid amide, ester, thioamide and thiol ester compounds bearing aryl or heteroaryl groups having sphingosine-1-phosphate (S1P) receptor antagonist biological activity
|
|
CN101460458A
(zh)
*
|
2006-02-15 |
2009-06-17 |
阿勒根公司 |
具有1－磷酸－鞘氨醇(s1p)受体拮抗剂生物活性的带芳基或者杂芳基基团的吲哚－3－羧酸的酰胺、酯、硫代酰胺和硫羟酸酯化合物
|
|
EP2014652B1
(en)
|
2006-04-18 |
2014-08-06 |
Nippon Chemiphar Co., Ltd. |
Activating agent for peroxisome proliferator activated receptor
|
|
DE102006021733A1
(de)
*
|
2006-05-09 |
2007-11-22 |
Bayer Healthcare Ag |
3-Tetrazolylindazole und 3-Tetrazolylpyrazolopyridine sowie ihre Verwendung
|
|
CA2652152A1
(en)
*
|
2006-05-16 |
2007-11-29 |
Decode Genetics Ehf |
Process for preparing 7-(acryloyl)indoles
|
|
DE102006043443A1
(de)
*
|
2006-09-15 |
2008-03-27 |
Bayer Healthcare Ag |
Neue aza-bicyclische Verbindungen und ihre Verwendung
|
|
EP2125723A1
(en)
*
|
2007-01-11 |
2009-12-02 |
Allergan, Inc. |
6-substituted indole-3-carboxylic acid amide compounds having sphingosine-1-phosphate (s1p) receptor antagonist biological activity
|
|
US8524917B2
(en)
|
2007-01-11 |
2013-09-03 |
Allergan, Inc. |
6-substituted indole-3-carboxylic acid amide compounds having sphingosine-1-phosphate (S1P) receptor antagonist biological activity
|
|
MX2010011252A
(es)
|
2008-04-15 |
2010-11-30 |
Nippon Chemiphar Co |
Activador para el receptor activado por el proliferador de peroxisoma.
|
|
US8546431B2
(en)
|
2008-10-01 |
2013-10-01 |
Panmira Pharmaceuticals, Llc |
5-lipoxygenase-activating protein (FLAP) inhibitors
|
|
DE102008063992A1
(de)
|
2008-12-19 |
2010-09-02 |
Lerner, Zinoviy, Dipl.-Ing. |
Neue aliphatisch substituierte Pyrazolopyridine und ihre Verwendung
|
|
NZ601967A
(en)
|
2010-03-12 |
2015-03-27 |
Omeros Corp |
Pde10 inhibitors and related compositions and methods
|
|
WO2012087833A1
(en)
|
2010-12-22 |
2012-06-28 |
Abbott Laboratories |
Hepatitis c inhibitors and uses thereof
|
|
CA2901636A1
(en)
|
2013-02-21 |
2014-08-28 |
Adverio Pharma Gmbh |
Forms of methyl {4,6-diamino-2-[1-(2-fluorobenzyl)-1h-pyrazolo[3,4-b]pyridino-3-yl]pyrimidino-5-yl}methyl carbamate
|
|
NZ716462A
(en)
|
2014-04-28 |
2017-11-24 |
Omeros Corp |
Optically active pde10 inhibitor
|
|
NZ630810A
(en)
|
2014-04-28 |
2016-03-31 |
Omeros Corp |
Processes and intermediates for the preparation of a pde10 inhibitor
|
|
HRP20211778T1
(hr)
|
2014-08-29 |
2022-03-18 |
Chdi Foundation, Inc. |
Kontrastna sredstva za slikovnu dijagnostiku huntingtin proteina
|
|
CA2980801A1
(en)
|
2015-04-24 |
2016-10-27 |
Omeros Corporation |
Pde10 inhibitors and related compositions and methods
|
|
CA3003611C
(en)
|
2015-11-04 |
2022-11-01 |
Omeros Corporation |
Solid state forms of a pde10 inhibitor
|
|
BR112020009361A2
(pt)
|
2017-11-17 |
2020-10-13 |
Cellix Bio Private Limited |
composto de fórmula i, composição farmacêutica para tratar um distúrbio ocular ou complicações do mesmo, método de síntese de composto, método de tratamento de um distúrbio ocular ou complicações do mesmo em um indivíduo que precisa do mesmo e uso de um composto
|